Aktienanalyse wird geladen …
ALB · NYSE · Specialty Chemicals · USA
108,25 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5,14 Mrd. | -510,63 Mio. | -5,76 $ | 117,66 Mio. | 0,4 Mio · 0,3 % | 0,2 Mio · 0,2 % | 13 % | -9,9 % | 5,89 $ | 0,34 $ | 1,62 $ |
| 2024 | 5,38 Mrd. | -1,18 Mrd. | -11,20 $ | 117,52 Mio. | 0,3 Mio · 0,3 % | — | 1,2 % | -21,9 % | -8,45 $ | 0,27 $ | 1,61 $ |
| 2023 | 9,62 Mrd. | 1,57 Mrd. | 13,36 $ | 117,77 Mio. | 0,3 Mio · 0,3 % | 0,4 Mio · 0,3 % | 12,3 % | 16,4 % | -7,03 $ | 0,31 $ | 1,60 $ |
| 2022 | 7,32 Mrd. | 2,69 Mrd. | 22,84 $ | 117,79 Mio. | 0,3 Mio · 0,2 % | — | 42 % | 36,8 % | 5,49 $ | 0,26 $ | 1,58 $ |
| 2021 | 3,33 Mrd. | 123,67 Mio. | 1,06 $ | 116,54 Mio. | 0,2 Mio · 0,2 % | — | 30 % | 3,7 % | -5,23 $ | 0,17 $ | 1,56 $ |
| 2020 | 3,13 Mrd. | 375,76 Mio. | 3,52 $ | 106,81 Mio. | 0,2 Mio · 0,2 % | — | 31,8 % | 12 % | -0,48 $ | 0,21 $ | 1,54 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Bruttomarge | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,74 Mrd. | 479,96 Mio. | 3,52 $ | — | 33,9 % | 27,5 % | — |
| Q1 2026 | 1,43 Mrd. | 319,09 Mio. | 2,69 $ | 118,61 Mio. | 35,1 % | 22,3 % | 2,09 $ |
| Q4 2025 | 1,43 Mrd. | -414,18 Mio. | -3,52 $ | 117,7 Mio. | 13,9 % | -29 % | 1,98 $ |
| Q3 2025 | 1,31 Mrd. | -160,69 Mio. | -1,37 $ | 117,69 Mio. | 9 % | -12,3 % | 1,90 $ |
| Q2 2025 | 1,33 Mrd. | 22,9 Mio. | 0,19 $ | 117,67 Mio. | 14,8 % | 1,7 % | -1,09 $ |
| Q1 2025 | 1,08 Mrd. | 41,35 Mio. | 0,35 $ | 117,6 Mio. | 14,5 % | 3,8 % | 3,10 $ |
| Q4 2024 | 1,23 Mrd. | 75,29 Mio. | 0,64 $ | — | 11,2 % | 6,1 % | -2,95 $ |
| Q3 2024 | 1,35 Mrd. | -1,07 Mrd. | -9,10 $ | 117,54 Mio. | -7,7 % | -78,9 % | -0,65 $ |
Albemarle (ALB) Falls More Steeply Than Broader Market: What Investors Need to Know
Is Albemarle Stock Outperforming the S&P 500?
Wall Street Bulls Look Optimistic About Albemarle (ALB): Should You Buy?
Albemarle (ALB) Stock Sinks As Market Gains: Here's Why
Albemarle (ALB) Stock Sees Fair Value Cut As Analysts Reset Lithium Assumptions
Mizuho Securities Adjusts Albemarle Price Target to $140 From $160, Maintains Neutral Rating
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
Albemarle Corporation is a global specialty chemicals company focused on lithium, bromine, and catalyst solutions. Albemarle supplies critical materials used in energy storage, electric mobility, electronics, construction, agriculture, pharmaceuticals, and petroleum refining. Its lithium products support battery supply chains for grid storage and transportation, while its bromine specialties serve flame retardants and other industrial applications. The company’s catalysts business provides technologies used in refining and chemical processing, helping customers improve product performance and operational efficiency. Albemarle operates across multiple regions and serves a broad international customer base through its Energy Storage, Specialties, and Ketjen segments. Headquartered in Charlotte, North Carolina, Albemarle plays a significant role in the specialty materials market by transforming essential resources into ingredients used in modern industrial and consumer applications.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest ALB und jede andere Aktie unbegrenzt.